CMS Final Coverage Policy for NGS Cancer Panels Eases Some Lab Industry Concerns

The US Centers for Medicare & Medicaid Services on Friday reined in a national coverage proposal for next-generation sequencing oncology panels that had the lab industry worried that they’d have to successfully take their tests through US Food and Drug Administration’s review if they hoped to secure Medicare coverage and had cancer patients vexed that the government payor was limiting their access to precision medicine.
 

Source: https://www.genomeweb.com/sequencing/cms-final-coverage-policy-ngs-cancer-panels-eases-some-lab-industry-concerns